Press release
Chronic Plaque Psoriasis Therapeutics Market: Industry Analysis, Growth, Trends and Forecast 2017 – 2025
Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type of psoriasis. This disease condition is associated with several risk factors such as infection, psychological stress and others. Diagnosis of chronic plaque psoriasis is based on clinical appearance, is the case is severe then biopsy is recommended by the healthcare professionals in order to distinguish it from other conditions such as seborrheic dermatitis, ichen simplex chronicus and others.Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/21442
Increasing uptake of biological drugs is one of the major factor propelling the growth of the global chronic plaque psoriasis therapeutics market. Advances in inflammation and immunology research, introduction of innovative drugs and increased focus on the usage of combination therapies are further accentuating the demand for chronic plaque psoriasis drugs. Adverse side effects, however, side-effects associated with the treatment such as risk of skin cancer, headache, hair loss, suppression of immunity and others could pose a major threat to the global chronic plaque psoriasis therapeutics market. Ixekizumab, tofacitinib, baricitinib, tregalizumab, ponesimod, AbGn-168H, E-6201, briakinumab, adalimumab and others are some of the drugs currently in clinical trials for the treatment of chronic plaque psoriasis.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/21442
Geographically, North America forms the largest regional market for chronic plaque psoriasis therapeutics. In addition, developed countries such as Germany, France, Spain, Italy, the U.K and Japan accounts for the second largest share of the global chronic plaque psoriasis therapeutics market due to emergence of new formulations.
The key manufacturers engaged in developing the chronic plaque psoriasis therapeutics market include Abbvie, Inc., Novartis International AG, Pfizer, Inc., Merck & Co., Astelllas Pharma, Inc., GlaxoSmithKline Plc and others.
Need more information about Report methodology ? @ https://www.persistencemarketresearch.com/methodology/21442
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
Telephone - +1-646-568-7751
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Plaque Psoriasis Therapeutics Market: Industry Analysis, Growth, Trends and Forecast 2017 – 2025 here
News-ID: 961037 • Views: …
More Releases from Persistence Market Research

Lactic Acid and Poly Lactic Acid Market Projected to Reach US$10.4 Bn by 2032 wi …
➤Overview of the Market
The global lactic acid and poly lactic acid (PLA) market is witnessing dynamic growth as industries pivot toward sustainable and bio-based solutions. Lactic acid, a naturally occurring organic acid, serves as a key building block for PLA, an environmentally friendly thermoplastic with a wide range of applications. Industries such as packaging, agriculture, textiles, and biomedical devices are increasingly adopting PLA due to its biodegradability, lower carbon footprint,…

Fulvic Acid Market to Reach US$1.8 Bn by 2032 on Back of Sustainable Agriculture …
➤ Overview of the Market
The fulvic acid market has been steadily gaining traction as industries increasingly recognize its multifaceted benefits in agriculture, dietary supplements, and environmental applications. Fulvic acid, a natural compound derived from humic substances, enhances nutrient absorption, improves soil fertility, and supports plant growth. In health and wellness, it is valued for its antioxidant, anti-inflammatory, and detoxifying properties. According to the latest study by Persistence Market Research, the…

Zika Virus Testing Market Growth Accelerates with Diagnostic Advancements, Notes …
The Zika virus testing market has grown into a crucial segment of global healthcare due to the unpredictable nature of mosquito-borne outbreaks and the virus's severe implications, particularly for maternal and fetal health. According to Persistence Market Research, the global Zika virus testing market size is projected to be valued at US$ 5.1 million in 2025 and is estimated to reach US$ 6.9 million by 2032, expanding at a CAGR…

APAC Gas Pressure Regulators Market, Strategic Insights, Key Players, and Region …
Market Overview
The APAC gas pressure regulators market has witnessed significant growth over recent years, fueled by rising industrialization, expanding energy infrastructure, and growing demand for safe and efficient gas distribution systems. Gas pressure regulators play a critical role in controlling and stabilizing gas flow and pressure across industrial, commercial, and residential applications, ensuring operational safety and efficiency. According to recent market estimates, the APAC gas pressure regulators market was valued…
More Releases for Psoriasis
Psoriasis Vulgaris Market
Introduction
Psoriasis vulgaris, also known as plaque psoriasis, is the most common form of psoriasis, accounting for nearly 80-90% of all cases. It is a chronic autoimmune condition marked by red, scaly plaques that can cause significant physical discomfort and emotional distress. Affecting millions worldwide, psoriasis vulgaris is increasingly recognized as both a dermatological and systemic disease due to its association with arthritis, cardiovascular disease, and metabolic syndrome.
The global psoriasis vulgaris…
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Psoriasis Market Size During the Forecast Period?
The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a…
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally.
Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to…
Psoriasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Psoriasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Pipeline Review, H1 2017, provides an overview of the Psoriasis (Immunology) pipeline landscape.
Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up…
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It…